Perhaps we were a trifle hasty ...
-SWS wrote:That pretty much settles the matter in my mind: "FOT is for naught" where A10 is concerned.
But I still wonder why Resmed has continued this highly basic FOT patent for so many years. Perhaps the decision is based on nothing more than a "FOT because we ought" philosophy.
Snoredog wrote:Fact is you don't know for sure if they have used it or not. If their technique differs from FOT as you say it does then it is not FOT it is something else like IOS or some other technique.
There are plenty of papers on FOT and xpap therapy, only thing is not many with Resmeds name on it.
Well, darned if FOT didn't crop up again in 2006 Patent 6,988,498, filed in 2002 and Continuation-In-Part from the 1998 application.
Patent 6,988,498 wrote:As previously discussed, one prior art method for avoiding unnecessary increases in pressure in response to open airway apneas is to determine the conductance of the airway during an apnea using the forced oscillation method, and only increase mask pressure if the conductance is less than a threshold. However, if the nasal airway is narrow or if the subject has lung disease, the airway conductance may be low even in the presence of an open airway and the forced oscillation method may still falsely increase pressure in response to open airway apneas. Conversely, the combination of the forced oscillation method with embodiments of the present invention has the added advantage that in most cases open airway apneas are correctly detected by the 'forced oscillation method', but in those cases where the forced oscillation method falsely reports a closed airway, the mask pressure will not increase above 10 cm H2O, thus preventing run-away increases in pressure. This is demonstrated in a third embodiment using the following pseudocode:
Just a couple of things worth mentioning about this:
1) ResMed coined the phrase Forced Oscillation Method (FOM), possibly to differentiate it from FOT.
2) FOM usage is specified in close accord with the speculation provided by -SWS.
3) The Claims section of the patent contains FOM as highlighted below:
Claims in Patent 6,988,498 wrote:1. A method for the administration of CPAP treatment pressure comprising the steps of: supplying breathable gas to a patient's airway at an initial treatment pressure, and repeatedly: determining a measure of respiratory airflow; determining the occurrence of an apnea from a reduction in said measure of respiratory airflow below a threshold; determining the duration of said apnea; and increasing the treatment pressure by an amount which is an increasing function of the duration of said apnea, and a decreasing function of the treatment pressure immediately before said apnea.
2. CPAP treatment apparatus comprising: a controllable flow generator operable to produce breathable gas at a pressure elevated above atmosphere; a gas delivery tube coupled to the flow generator; a patient mask coupled to the tube to receive said breathable gas from the generator and provide said gas, at a desired treatment pressure, to the patient's airway; a controller operable to receive input signals and to control operation of said flow generator and hence the treatment pressure; and sensor means located at the flow generator, in the delivery tube or at the mask that generates a signal input to said controller from which patient respiratory airflow is determined; and wherein said controller is operable to determine the occurrence of an apnea from a reduction in said respiratory airflow, determine the duration of said apnea, and cause said flow generator to increase CPAP treatment pressure by an increment that is an increasing function of said apnea duration and a decreasing function of the treatment pressure immediately prior to said apnea.
3. The CPAP treatment apparatus of claim 2, wherein there is a further determination of the occurrence of at least partial upper airway obstruction by the controller being further operable to detect the presence of characteristic changes in shape of an inspiratory flow versus time curve indicative of inspiratory airflow limitation.
4. A method for the administration of CPAP treatment pressure comprising the steps of: supplying breathable gas to the patient's airway at a treatment pressure; determining a measure of respiratory airflow; and determining the occurrence of an apnea from a reduction in the measure of respiratory airflow below a threshold, and, if having occurred, (i) determining the duration of the apnea; and (ii) increasing the treatment pressure by an amount which is an increasing function of the duration of the apnea, and a decreasing function of the treatment pressure immediately before the apnea.
5. The method of claim 4, wherein the increase in treatment pressure is substantially zero if the treatment pressure before the apnea exceeds a pressure threshold.
6. The method of claim 5, wherein the increase in pressure below the pressure threshold is an increasing function of the duration of the apnea, multiplied by the difference between the pressure threshold and the current treatment pressure.
7. The method of claim 6, wherein said increasing function of apnea duration is linear on apnea duration.
8. The method of claim 5, in which the pressure threshold is substantially 10 cm H2O.
9. The method of claim 4, wherein the occurrence of an apnea is determined by the steps of: calculating the RMS respiratory airflow over a short time interval; calculating the RMS respiratory airflow over a longer time interval; and determining an apnea if the RMS respiratory airflow over the short time interval is less than a predetermined fraction of the RMS respiratory airflow over the longer time interval.
10. The method of claim 4, comprising the further step of reducing the treatment pressure towards an initial treatment pressure in the absence of a further apnea.
11. The method of claim 4, comprising the further steps of: in the absence of an apnea, determining the presence of partial obstruction; and if present, increasing the treatment pressure.
12. The method of claim 11, in which the presence of partial obstruction is determined from the shape of the patient's inspiratory flow vs time curve.
13. The method of claim 11, in which the presence of partial obstruction is determined from the presence of snoring.
14. The method of claim 11, in which the presence of partial obstruction is determined from both the shape of the patient's inspiratory flow vs time curve, and from the presence of snoring.
15. The method of claim 14, in which the patency of the airway is determined by the presence of a cardiogenic component in the respiratory airflow.
16. The method of claim 14, in which the patency of the airway is determined by the steps of: modulating the treatment pressure at a known frequency; measuring the component of the respiratory airflow at said modulation frequency; calculating the conductance of the airway as the ratio of the amplitude of said component of the respiratory airflow to the amplitude of the mask pressure modulation; and determining that the airway is patent if the conductance exceeds a conductance threshold.
17. The method of claim 4, comprising the further steps of: if an apnea is occurring, determining whether the patient's airway is patent during the apnea; and if the airway is patent, setting the increase in treatment pressure to zero.
It is also worth noting that the methods in these claims evaluate snoring, flow limitations, flow vs time, and cardiogenic activity to determine a suitable response to apnea. Hypopneas, per se, are not a component of the ResMed algorithm, just as Velbor (I think) pointed out.
Regards,
Bill